3-iodobenzylguanidine has been researched along with levodopa in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bombardieri, E; Chiti, A; De Deckere, E; Maccauro, M; Savelli, G | 1 |
| Garske, U; Orlefors, H; Sundin, A | 1 |
| Kim, JS; Lee, KS; Song, IU | 1 |
| Hamamoto, M; Katayama, Y; Mori, O; Nagayama, H; Nishiyama, Y; Ueda, M; Yamazaki, M | 1 |
| Miyashita, Y; Saiki, A; Sakakibara, R; Shirai, K; Tateno, F | 1 |
| Arabia, G; Bagnato, A; Cascini, GL; Cipullo, S; Condino, F; Messina, D; Morelli, M; Morgante, L; Nicoletti, G; Novellino, F; Paglionico, S; Pugliese, P; Quattrone, A; Salsone, M | 1 |
| Kishi, M; Ogawa, E; Sakakibara, R; Tateno, T; Terada, H | 1 |
| Inoue, M; Inoue, Y; Kishimoto, T; Kiuchi, K; Kosaka, J; Morikawa, M; Norimoto, K | 1 |
| Asayama, S; Asayama, T; Fujita, K; Ito, H; Kaneko, S; Kusaka, H; Morita, J; Nagashima, M; Nakamura, M; Nakamura, S; Nakano, S; Nishii, M; Oki, M; Saito, A; Tsuge, A; Wate, R | 1 |
| Chiaravalloti, A; Galati, S; Lauretti, B; Olivola, E; Pierantozzi, M; Pisani, V; Prosperetti, C; Rocchi, C; Schillaci, O; Stampanoni Bassi, M; Stefani, A | 1 |
| Kim, JS; Lee, JE; Lee, KS; Oh, YS; Ryu, DW; Yoo, IR | 1 |
2 review(s) available for 3-iodobenzylguanidine and levodopa
| Article | Year |
|---|---|
Nuclear medicine imaging of neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed | 2001 |
Nuclear imaging of neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Carbidopa; Glucose-6-Phosphate; Humans; Levodopa; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin | 2007 |
9 other study(ies) available for 3-iodobenzylguanidine and levodopa
| Article | Year |
|---|---|
Dopa-responsive camptocormia in a patient with multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Antiparkinson Agents; Female; Heart; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Multiple System Atrophy; Parkinson Disease; Posture; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Fatal Outcome; Humans; Levodopa; Lewy Body Disease; Male; Multiple System Atrophy; Myocardium; Radiopharmaceuticals | 2008 |
Levodopa might affect metaiodobenzylguanidine myocardial accumulation.
Topics: 3-Iodobenzylguanidine; Adult; Dopamine Agents; Humans; Levodopa; Male; Myocardium; Tremor | 2008 |
Cardiac MIBG scintigraphy in Primary Progressive Freezing Gait.
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Antiparkinson Agents; Disease Progression; Female; Gait; Gait Apraxia; Heart; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Treatment Outcome | 2009 |
Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging | 2011 |
Parkinsonism with multiple cysts in the bilateral striata.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Antipsychotic Agents; Brain Ischemia; Delirium; Delusions; Diagnosis, Differential; Dibenzothiazepines; Dominance, Cerebral; Drug Therapy, Combination; Encephalomalacia; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neostriatum; Neurologic Examination; Organophosphate Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced; Quetiapine Fumarate; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2013 |
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antiparkinson Agents; Autonomic Nervous System; Blood Pressure; Female; Hand Strength; Heart; Humans; Levodopa; Male; Middle Aged; Myocardial Perfusion Imaging; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Severity of Illness Index; Time Factors | 2015 |
Cardiac Sympathetic Denervation Can Predict the Wearing-off Phenomenon in Patients with Parkinson Disease.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Case-Control Studies; Disease Progression; Female; Heart; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2018 |